BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1014113)

  • 1. [In vitro development of macrophages from PHA-stimulated blood cultures in Hodgkin's disease and in chronic lymphocytic leukaemia (author's transl)].
    Navone R; Tosto M; Poggio E
    Tumori; 1976; 62(1):19-24. PubMed ID: 1014113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies of macrophages in blood cultures in Hodgkin's disease.
    Novone R; Palestro G; Resegotti L
    Acta Haematol; 1975; 53(1):25-9. PubMed ID: 807071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism.
    Ambrogi F; Grassi B; Ronca-Testoni S; Ronca G
    Clin Exp Immunol; 1977 Apr; 28(1):80-8. PubMed ID: 405169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Correlation between some enzymes of nucleotide catabolism, E rosette formation and PHA response of blood lymphocytes in Hodgkin's disease and chronic lymphocytic leukemia.
    Ronca G; Ronca Testoni S; Grassi B; Ambrogi F
    Ital J Biochem; 1976; 25(3):255-6. PubMed ID: 955858
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of Hodgkin cytotoxic serum on blast transformation of normal and Hodgkin human peripheral blood lymphocytes].
    Tognella S; Mantovani G; Del Giacco GS; Manconi PE; Cengiarotti L; Floris C; Grifoni V
    Tumori; 1975; 61(1):53-62. PubMed ID: 1226572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte transformation in immunoproliferative disorders.
    Catovsky D; Holt PJ; Galton DA
    Br J Cancer; 1972 Jun; 26(3):154-63. PubMed ID: 4114813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphocyte response in Hodgkin's disease.
    Braeman J; Evans IH; Deeley TJ
    Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PHA- and PWM-stimulation in acute leukaemia (author's transl)].
    Koeppen KM; Boll I
    Blut; 1978 Jun; 36(6):347-351. PubMed ID: 274967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane difference in peripheral blood lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.
    Mintz U; Sachs L
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2428-32. PubMed ID: 1056037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of the circulating cell in chronic lymphocytic leukemia.
    Schultz EF; Davis S; Rubin AD
    Blood; 1976 Aug; 48(2):223-34. PubMed ID: 1065390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
    Twomey JJ; Laughter AH; Lazar S; Douglass CC
    Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.